Medical Cannabis Evidence Gaps: Risks and Benefits Uncovered
A new review from UCLA Health reveals that medical cannabis may be less effective than many believe. Researchers found limited scientific evidence supporting its use for common conditions like chronic pain, anxiety, and insomnia. The findings appear as cannabis and CBD products continue to grow in popularity. The review, published in JAMA, examined over 2,500 studies from 2010 to 2025. It focused on more than 120 high-quality studies with large sample sizes and recent data. Survey data shows that about 27% of people in the U.S. and Canada use cannabis for pain, sleep, or anxiety.
Proven Benefits Are Narrow
Pharmaceutical-grade cannabinoids approved by the FDA show clear benefits only for specific conditions. These include appetite loss in HIV/AIDS, chemotherapy-induced nausea, and severe pediatric seizures. For most other uses, evidence remains unclear or insufficient. Even for chronic pain, current guidelines advise against cannabis as a first-line treatment. The review also found potential mental health and cardiovascular risks. High-potency cannabis may increase psychotic symptoms and anxiety, especially in adolescents. About 29% of medical cannabis users met criteria for cannabis use disorder. Daily use may raise the risk of heart disease, heart attack, and stroke. Clinicians are advised to screen for heart issues and mental health disorders before recommending THC products.
Guidance and Future Research
Researchers stress honest conversations between doctors and patients about cannabis benefits and risks. They also call for more rigorous studies to clarify medical cannabis’ effectiveness and safety. Clear guidance will help patients make informed, evidence-based decisions.
